$342.50
4.981.48%
Last update: Nov 9, 9:04 AM
Charles River Laboratories International Inc
CRLNYSE
The average analyst price target for Charles River is $285.05, 16.8% below the current price. Of 18 analysts, 13 rate it Buy and 5 Hold. Targets range from $167 to $400. The latest change came on Nov 5, 2026, when UBS raised its price target on Charles River from $357 to $387 and kept a Buy rating.
Price Target Range — 12 Quarters
Analyst Consensus — 18 Analysts
Rating Trend — Last 9 Months
